Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, August 07, 2023 to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. Further, pursuant to the Company’s Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons, shall remain closed upto 48 hours after the conclusion of the aforesaid Board Meeting.
The above information is a part of company’s filings submitted to BSE.
